MARCUZZI, ANNALISA
 Distribuzione geografica
Continente #
NA - Nord America 8.628
EU - Europa 4.920
AS - Asia 2.976
SA - Sud America 413
AF - Africa 117
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 9
Totale 17.076
Nazione #
US - Stati Uniti d'America 8.543
PL - Polonia 2.518
SG - Singapore 1.101
CN - Cina 727
SE - Svezia 494
IT - Italia 362
VN - Vietnam 350
HK - Hong Kong 319
UA - Ucraina 318
BR - Brasile 317
DE - Germania 232
FR - Francia 216
FI - Finlandia 143
GB - Regno Unito 140
RU - Federazione Russa 117
KR - Corea 108
TR - Turchia 107
NL - Olanda 97
BG - Bulgaria 78
IE - Irlanda 73
IN - India 63
CA - Canada 39
MA - Marocco 30
BD - Bangladesh 29
BE - Belgio 29
MX - Messico 28
IQ - Iraq 27
SN - Senegal 27
JP - Giappone 26
AR - Argentina 23
VE - Venezuela 22
ZA - Sudafrica 19
ES - Italia 17
CH - Svizzera 16
AT - Austria 14
CL - Cile 13
CO - Colombia 13
GR - Grecia 13
SA - Arabia Saudita 12
IL - Israele 11
TN - Tunisia 11
EU - Europa 9
PK - Pakistan 9
RO - Romania 9
AE - Emirati Arabi Uniti 8
EC - Ecuador 8
PH - Filippine 8
AU - Australia 7
TH - Thailandia 7
AZ - Azerbaigian 6
DK - Danimarca 6
ID - Indonesia 6
PY - Paraguay 6
UZ - Uzbekistan 6
DZ - Algeria 5
JO - Giordania 5
LT - Lituania 5
MY - Malesia 5
NP - Nepal 5
A2 - ???statistics.table.value.countryCode.A2??? 4
GA - Gabon 4
KE - Kenya 4
NG - Nigeria 4
PE - Perù 4
PT - Portogallo 4
AL - Albania 3
AM - Armenia 3
AO - Angola 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
EG - Egitto 3
GE - Georgia 3
IR - Iran 3
KZ - Kazakistan 3
LU - Lussemburgo 3
UY - Uruguay 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BO - Bolivia 2
BS - Bahamas 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
NO - Norvegia 2
OM - Oman 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
CD - Congo 1
CU - Cuba 1
CY - Cipro 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
FJ - Figi 1
FK - Isole Falkland (Malvinas) 1
GT - Guatemala 1
GY - Guiana 1
KG - Kirghizistan 1
Totale 17.057
Città #
Warsaw 2.449
Fairfield 899
Ashburn 853
Woodbridge 840
Singapore 736
Houston 674
Ann Arbor 625
Chandler 506
Seattle 433
Wilmington 417
San Jose 311
Hong Kong 309
Jacksonville 298
Cambridge 294
Beijing 164
Chicago 148
Princeton 136
Boardman 119
Los Angeles 117
Trieste 111
Ho Chi Minh City 110
Seoul 103
Dallas 89
Dearborn 84
Columbus 78
Sofia 77
Lauterbourg 75
Hanoi 74
Dublin 72
Izmir 72
Hefei 71
Zgierz 59
Santa Clara 56
Frankfurt am Main 51
Munich 50
Moscow 47
New York 46
Buffalo 42
Amsterdam 38
London 38
Salt Lake City 38
Council Bluffs 37
Helsinki 37
São Paulo 37
The Dalles 37
Dong Ket 36
San Diego 36
Falls Church 35
Orem 33
Düsseldorf 30
Brussels 27
Dakar 27
Grafing 26
Phoenix 26
Casablanca 25
Elk Grove Village 24
Jinan 23
Des Moines 22
Shanghai 22
Tokyo 22
Milan 21
Tampa 21
Kunming 20
Chennai 19
Washington 19
Redondo Beach 18
Nanjing 17
Brooklyn 16
Hebei 15
Portsmouth 15
Redwood City 15
Turku 15
Toronto 14
Da Nang 13
Guangzhou 13
Haiphong 13
Ankara 12
Atlanta 12
Johannesburg 12
Stockholm 11
Brasília 10
Bremen 10
Corinth 10
Montreal 10
Nuremberg 10
Tianjin 10
Can Tho 9
Denver 9
Fuzhou 9
Mumbai 9
Nanchang 9
Rio de Janeiro 9
San Francisco 9
Santiago 9
Belo Horizonte 8
Hangzhou 8
Kocaeli 8
Mexico City 8
Poplar 8
Rome 8
Totale 12.862
Nome #
The complex interplay between lipids, immune system and interleukins in cardio-metabolic diseases 625
Ex vivo response to mucosal bacteria and muramyl dipeptide in inflammatory bowel disease 480
Geranylgeraniol and Neurological Impairment: Involvement of Apoptosis and Mitochondrial Morphology 439
Neuronal Dysfunction Associated with Cholesterol Deregulation. 427
Alendronate, a double-edged sword acting in the mevalonate pathway 423
To extinguish the fire from outside the cell or to shutdown the gas valve inside? Novel trends in anti-inflammatory therapies 408
Curcumin anti-apoptotic action in a model of intestinal epithelial inflammatory damage 405
Type i interferon-mediated autoinflammation due to DNase II deficiency 389
Innovative Target Therapies Are Able to Block the Inflammation Associated with Dysfunction of the Cholesterol Biosynthesis Pathway. 386
Inflammatory bowel disease and patterns of volatile organic compounds in the exhaled breath of children: A case-control study using Ion Molecule Reaction-Mass Spectrometry 380
Two‑gene mutation in a single patient: Biochemical and functional analysis for a correct interpretation of exome results. 379
Repositioning Of Tak-475 In Mevalonate Kinase Disease: Translating Theory Into Practice 378
Pediatric patients with inflammatory bowel disease exhibit increased serum levels of proinflammatory cytokines and chemokines, but decreased circulating levels of macrophage inhibitory protein-1β, interleukin-2 and interleukin-17 360
Monocyte-predominant engraftment, cytokine levels and early transplant-related complications in pediatric hematopoietic stem cell recipients 320
Clinical Genetic Testing of Periodic Fever Syndromes 299
A common genetic background could explain early-onset Crohn's disease. 280
Curcumin and inflammatory bowel disease: Potential andlimits of innovative treatments 279
Altered germinal center reaction and abnormal B cell peripheral maturation in PI3KR1-mutated patients presenting with HIGM-like phenotype 276
Comments on ''Geranylgeraniol--a new potential therapeutic approach to bisphosphonate associated osteonecrosis of the jaw" by Ziebart T et al. (2011). 273
Antibodies reacting to mimotopes of Simian virus 40 large T antigen, the viral oncoprotein, in sera from children. 272
The farnesyltransferase inhibitors tipifarnib and lonafarnib inhibit cytokines secretion in a cellular model of mevalonate kinase deficiency. 271
Is autophagy an elective strategy to protect neurons from dysregulated cholesterol metabolism? 264
A comparative analysis of serologic parameters and oxidative stress in osteoarthritis and rheumatoid arthritis: reply to Mishra and colleagues 264
Decreased cholesterol levels reflect a consumption of anti-inflammatory isoprenoids associated with an impaired control of inflammation in a mouse model of mevalonate kinase deficiency. 263
Defect in mevalonate pathway induces pyroptosis in Raw 264.7 murine monocytes. 257
Cytokine profiles of women with vulvodynia: Identification of a panel of pro-inflammatory molecular targets 251
Natural isoprenoids inhibit LPS-induced-production of cytokines and nitric oxide in aminobisphosphonate-treated monocytes. 247
Cytokine levels in the serum of healthy subjects. 246
Long non-coding RNA gas5 and intestinal mmp2 and mmp9 expression: A translational study in pediatric patients with IBD 245
Comments to the editor concerning the paper entitled "Preclinical renal cancer chemopreventive efficacy of geraniol by modulation of multiple molecular pathways" Shiekh Tanveer Ahmad et al. 243
Microglia activation and interaction with neuronal cells in a biochemical model of mevalonate kinase deficiency 242
Letter to the editor: acute effects of intravenous administration of pamidronate in patients with osteoporosis. 238
Mevalonate kinase deficiency and IBD: shared genetic background 238
Block of the Mevalonate Pathway Triggers Oxidative and Inflammatory Molecular Mechanisms Modulated by Exogenous Isoprenoid Compounds 234
Database tools in genetic diseases research. 234
Evolutionary hypothesis of the Mevalonate Kinase Deficiency. 230
Inflammation profile of four early onset Crohn patients. 226
Targeting farnesyl-transferase as a novel therapeutic strategy for mevalonate kinase deficiency: In vitro and in vivo approaches. 222
Natural isoprenoids are able to reduce inflammation in a mouse model of mevalonate kinase deficiency. 220
Lovastatin dose-dependently potentiates the pro-inflammatory activity of lipopolysaccharide both in vitro and in vivo 217
Putative modifier genes in mevalonate kinase deficiency 210
Family history in early-onset inflammatory bowel disease 207
Letter: inflammatory bowel disease, complementary and alternative medicine, and genetics 205
Farnesyl and geranylgeranyl transferase inhibitors: an anti-inflammatory effect. Comment to "Inhibition of protein geranylgeranylation and farnesylation protects against graft-versus-host disease via effects on CD4 effector T cells" Haematologica. 2013;98(1):31-40 198
The Challenge of Next Generation Sequencing in a Boy with Severe Mononucleosis and EBV-related Lymphoma 198
Microcapsule a doppio strato di polisaccaridiutilizzabili come veicoli per la somministrazione oraledi sostanze biologicamente attive 193
Serum amyloid A and cholesterol: a pivotal role on inflammation. 186
Lovastatin induces apoptosis through the mitochondrial pathway in an undifferentiated SH-SY5Y neuroblastoma cell line 184
Mevalonate kinase deficiency: therapeutic targets, treatments, and outcomes 173
Autoinflammatory syndromes and coeliac disease: One observation and two hypotheses 168
Mevalonate Kinase Deficiency and Neuroinflammation: Balance between Apoptosis and Pyroptosis 168
Specific protein profile in cerebrospinal fluid from HIV-1-positive cART-treated patients affected by neurological disorders. 164
Temperature and Drug Treatments in Mevalonate Kinase Deficiency: An Ex Vivo Study 162
Geraniol rescues inflammation in cellular and animal models of mevalonate kinase deficiency 159
Mevalonate kinase deficiency: disclosing the role of mevalonate pathway modulation in inflammation. 150
Lovastatin-induced apoptosis is modulated by geranylgeraniol in a neuroblastoma cell line. 149
New Mechanisms in Autoinflammatory Diseases 146
MIF plasma level as a possible tool to predict steroid responsiveness in children with idiopathic nephrotic syndrome 146
Clarification of the pleiotropic effects of statins on mevalonate pathway and the feedback regulation of isoprenoids requires more comprehensive investigation. 143
Presence of IL-9 in paired samples of human colostrum and transitional milk. 141
Defibrotide impact on the acute GVHD disease incidence in pediatric hematopoietic stem cell transplant recipients 130
null 130
Post-Irradiation Hyperamylasemia Is a Prognostic Marker for Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in Pediatric Population: A Retrospective Single-Centre Cohort Analysis 129
Standard treatment–refractory cytomegalovirus encephalitis unmasked by immune reconstitution inflammatory syndrome and successfully treated with virus-specific hyperimmune globulin 127
TRAIL administration down-modulated the acute systemic inflammatory response induced in a mouse model by muramyldipeptide or lipopolysaccharide. 124
Mouse model of mevalonate kinase deficiency: comparison of cytokines and chemokines profile with human patients 120
The effect of clodronate on a mevalonate kinase deficiency cellular model. 115
null 109
null 108
New Applications of JAK/STAT Inhibitors in Pediatrics: Current Use of Ruxolitinib 107
Role of vitamin D in the pathogenesis of atheromatosis 106
null 86
Mevalonate kinase deficiency and squalene synthase inhibitor (TAK-475): The balance to extinguish the inflammation 85
Systemic and neuronal inflammatory markers in a mouse model of mevalonate kinase deficiency: a strain-comparative study. 76
Lysozyme-containing chitosan-coated arginate microspheres for oral immunisation 55
Totale 17.387
Categoria #
all - tutte 42.066
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.066


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021380 0 0 0 0 0 0 0 0 0 190 67 123
2021/2022974 48 50 56 59 78 102 58 18 98 91 77 239
2022/20231.384 164 201 118 206 117 246 1 109 145 10 56 11
2023/2024805 33 57 56 54 81 99 160 148 14 9 56 38
2024/20251.692 26 80 159 173 170 106 154 57 208 219 178 162
2025/20264.006 729 154 298 371 384 345 662 145 511 407 0 0
Totale 17.387